RTL5

Across TCGA pan-cancer cohorts, RTL5 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated RTL5 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RTL5 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated RTL5 expression acts as an unfavorable survival marker.

BRCA, BLCA, and HNSC are the cancer types where RTL5 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Median	All	0.019	0.950	<.001	36	view →
BLCA	OS	Median	IV	0.130	0.599	.002	12	view →
HNSC	OS	Median	IV	0.138	0.641	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RTL5–BRCA (DFS)

Open the BRCA breakdown →